Hepatitis
and Its Impact on Life Insurance Prices
Do all types of hepatitis have the same affect
on life insurability?
Affordable Life Insurance Policy for Hepatitis A, B and
C
Hepatitis is the most significant blood-borne epidemic
in the United States and is responsible for approximately
100,000 infections every year. It is a disease that causes
inflammation of the liver and results from a viral infection,
from exposure to substances that are toxic to the liver
or from an autoimmune disorder. Hepatitis can be an acute
illness with no long term negative impact or it may be
chronic or terminal, leading to death. Insurers will evaluate
a person’s insurability based upon the type of hepatitis
and the level of success achieved in treating it.
Understanding Different Types of Hepatitis
Hepatitis A, B and C cause varying degrees of liver
inflammation. Acute hepatitis can be caused by
hepatitis A; chronic hepatitis can be caused by hepatitis
B (HBV), hepatitis C (HCV), hepatitis D (HDV), autoimmune
diseases such as lupus,
various medications, and unknown causes. Learn more on
Hepatitis A, Hepatitis
B and Hepatitis C.
Other related medical conditions
(or medical terminology) include Liver Disease, Liver
Cirrhosis, Liver Inflammation, Hep C, Liver Biopsy, Liver
Disorders, Seizure Disorder, Viral Load, Acute Hepatitis.
Read below for more information on receiving a life
insurance quote with these medical conditions.
Hepatitis A
The most common
type of hepatitis, as well as the least serious variation
of the disease, is hepatitis A. Unlike hepatitis
B or C, it will not evolve into a chronic condition. It
causes inflammation of the liver; however, it does not
usually lead to long-term liver problems and, in most cases,
resolves on its own.
This type of hepatitis is contracted after ingesting contaminated
food or water or through contact with a person who is currently
ill with the disease. The hepatitis A virus is found in
the stools of an infected person, or in other bodily secretions,
two to seven weeks before symptoms occur and during the
first week of illness. It spreads when proper hand
cleaning doesn’t occur after bathroom use. It
is easily spread at restaurants by employees’ with
dirty hands, at day care centers, nursing homes and rehabilitation
centers when workers don’t wash their hands properly
after changing a diaper or cleaning a patient. People,
who eat raw oysters or undercooked clams, as well as travelers
visiting a country where hepatitis A is common, are at
an increased risk of developing hepatitis A.
Over 85% of people with hepatitis A recover within three
months, and over 99% of people recover by six months.
Hepatitis B
Hepatitis B is a virus that is transmitted through blood
transfusions, contact with blood in health care settings,
through use of contaminated acupuncture needles, tattoo
instruments, or shared needles used by drug abusers and
during unsafe sex with an infected person. It can
be passed from an infected mother to an infant during
childbirth.
It takes from one to six months from the time of infection
for symptoms of acute hepatitis appear. The risk of becoming
chronically infected depends on your age at the time of
infection. Most newborns, and about 50% of children infected
with hepatitis B, develop chronic hepatitis whereas only
a few adults infected with HBV develop the chronic condition.
Most of the damage from the hepatitis B virus is due to
the body's response to the infection. When the body's immune
system detects the infection, it sends out special cells
to fight it off, however, these disease-fighting cells
can cause liver inflammation. The liver damage also interferes
with the body's ability to get rid of bilirubin which causes
jaundice and may progress into a chronic condition.

Hepatitis C
Hepatitis C causes severe liver damage that can lead to
deadly health problems. It is spread by infected
blood products, shared needles, especially among IV drug
users, sexual contact and mother-to-child transmission.
Prior to 1992, there was no effective blood screen for
the virus and anyone with a blood transfusion prior to
that date is at risk. Unlike Hepatitis A or B, there is
no preventative vaccine for this disease. People who may
be at risk for hepatitis C include long-term kidney dialysis
patients, healthcare workers, persons who practice unprotected
sex or who use injectible street drugs or individuals who
share personal items such as toothbrushes or razors with
someone who has the disease.
Although its impact may take decades to become serious,
approximately 80 percent of affected individuals with untreated
hepatitis C develop chronic inflammation of the liver and
severe liver disease. Of those, 10 – 20 percent
will develop cirrhosis,
a chronic progressive disease that causes scar tissue in
the liver, and one to five percent will develop liver cancer.
Identifying Symptoms and Treating Hepatitis
Symptoms of hepatitis
do not always present themselves immediately. In acute
cases, symptoms of hepatitis A and B are similar to the
flu, last for about two months and may include fatigue,
nausea, and loss of appetite, unintended weight loss, stomach
pain, fever and sore muscles. The skin and eyes may become
jaundiced, or yellow,
due to the liver’s inability
to filter the chemical bilirubin,
a breakdown product of old red blood cells in the body. Older
individuals may also produce dark urine and clay-colored
stools. People infected with hepatitis C are often asymptomatic
for many years until the liver develops cirrhosis. Symptoms
then are similar to hepatitis A and B, but may also include
pain in the upper right quadrant of the abdomen, ascites (fluid
in the abdominal cavity), bleeding
varices (dilated
veins in the esophagus) and generalized itching.
Hepatitis is often found during blood tests for a routine
physical or other medical procedure. If, due to symptoms,
hepatitis is suspected, a doctor will perform a physical
examination to see the liver appears enlarged or tender.
Lab work will be ordered to screen for hepatitis antibodies
IgM and IgG, elevated liver enzymes, low albumin levels
and increased prothrombin time. A liver biopsy may
be ordered.
Once
the type of hepatitis is identified, a treatment plan will
be developed. As there is no specific treatment
for hepatitis A, rest
is recommended during the acute phase of the disease when
the symptoms are most severe. People with acute hepatitis
are advised to avoid alcohol and any substances that are
toxic to the liver, including acetaminophen (Tylenol).
As fatty foods may cause vomiting, because secretions from
the liver are needed to digest fats, they should also be
avoided. Similarly, hepatitis
B warrants
no medical treatment other than careful monitoring of liver
function through blood tests unless it progresses into
chronic hepatitis. Rest may be recommended during
the acute phase of the disease when the symptoms are most
severe. Those without liver involvement are usually monitored
at least yearly to evaluate liver function, detect complications
and provide treatment when necessary. Individuals
with hepatitis C and chronic
hepatitis,
who have evidence of liver disease, are sometimes treated
with drugs to treat infections and reduce inflammation.
Hepatitis C patients are advised to abstain from alcohol,
vitamins, nutritional supplements or over-the-counter medications,
restrict protein intake and vaccinate against hepatitis
A and B infections. There no cure for hepatitis C,
but medications in some cases can suppress the virus for
a long period of time. Treatment with interferon
alpha or a combination of interferon
alpha and ribavirin,
an antiviral medication, called pegylated
interferon alpha,
may result in a "sustained response" which means
the patient remains free of the hepatitis C virus six months
after treatment has been discontinued. This does not mean
that the patient is cured, but that the levels of active
hepatitis C virus in the body are very low and are probably
not causing more or as much damage. On
the other end of the spectrum, in cases when liver failure
occurs, monitoring in a hospital intensive care unit (ICU)
until a liver transplant becomes
available may be necessary. A liver transplant is the only
cure in cases of liver failure.
How Underwriters View Hepatitis and Insurability
Life insurance underwriters evaluating applications from
individuals with a history of hepatitis will want documentation
regarding the type of disease (acute or chronic), onset
of disease, the absence or presence of symptoms, the results
of liver function tests and, some instances, biopsies,
as well as an assessment of how a patient has responded
to treatment.
Just as there is variation in hepatitis and how it affects
an individual’s health in the short term and long
run, there is variation in offers of insurance to those
affected. Completely resolved cases of acute hepatitis
A or B may receive preferred or standard offers even though
antigens are present. In chronic hepatitis and hepatitis
C cases, underwriters will evaluate the degree of enzyme
elevation, stage of liver disease and quality of life,
to when rating offers. Although many companies will
decline chronic hepatitis C outright, some will consider
individuals who have been "cured" for at least
two years as documented by negativehepatitis
screens.
How Can MEG Financial Help?
At MEG Financial, we have worked
with many individuals across the country that have had
hepatitis related histories
and have helped many obtain fairly priced life insurance.
A number of these clients previously attempted to buy life
insurance elsewhere but were either turned down or asked
to pay a significantly higher rate. Our experience helping
others with alcohol related problems is invaluable to you
in identifying the insurance company that will treat you
most fairly.
For more specific information or
to obtain a custom quote, call MEG Financial today at
(877) 583-3955. You may also
submit this short form and an independent insurance agent
will personally contact you to go over any questions or
other concerns.
Related
Links for Hepatitis A, B, and C Life Insurance Policy

|
 |